ZB
CLB icon

Zions Bancorporation’s Core Laboratories CLB Stock Holding History

Zions Bancorporation’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-517
Closed -$51K – 679
2017
Q3 		$51K Buy
+517
New +$50.1K 0.01% 562
2017
Q1 		– Sell
-11
Closed -$1K – 742
2016
Q4 		$1K Hold
11
– – ﹤0.01% 809
2016
Q3 		$1K Hold
11
– – ﹤0.01% 775
2016
Q2 		$1K Hold
11
– – ﹤0.01% 757
2016
Q1 		$1K Hold
11
– – ﹤0.01% 815
2015
Q4 		$1K Hold
11
– – ﹤0.01% 774
2015
Q3 		$1K Buy
+11
New +$1.2K ﹤0.01% 787
2015
Q2 		– Sell
-11
Closed -$1K – 348
2015
Q1 		$1K Buy
+11
New +$1.17K ﹤0.01% 858

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Zions Bancorporation's CLB Position: Q4 2017 in Review

Zions Bancorporation sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 517 shares — an estimated $51K sold.

Zions Bancorporation first reported a position in CLB in Q1 2015 and held it in 8 quarters. The position peaked at $51K in Q3 2017. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • Zions Bancorporation reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • Zions Bancorporation sold 517 Core Laboratories shares in Q4 2017, an estimated $51K.
  • Zions Bancorporation first reported a position in Core Laboratories in Q1 2015 and held it in 8 quarters.
  • Zions Bancorporation's Core Laboratories position peaked at $51K in Q3 2017.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Zions Bancorporation's 13F filing for Q4 2017, filed 14 Feb 2018.